Sanofi opens new $925M manufacturing facility in Toronto

{
  "signal_id": "824f8d2a-07ce-1df2-1b53-512a44a66459",
  "signal_type": "news",
  "signal_subtype": "invests_into_assets",
  "detected_at": "2026-09-24T15:11:17+00:00",
  "company": {
    "name": "Sanofi",
    "domain": "sanofi.com"
  },
  "data": {
    "url": "https://renx.ca/sanofi-opens-new-925m-manufacturing-facility-in-toronto",
    "title": "Sanofi opens new $925M manufacturing facility in Toronto - RENX.ca",
    "assets": "real estate portfolio",
    "excerpt": "Sanofi Canada has inaugurated its new $925-million facility to produce flu vaccines in Toronto, the Charles Best Building. The French pharmaceutical manufacturer said the investment, which included $415 million in federal funding and $55 million from the Government of Ontario, was the single-largest investment in a biomanufacturing facility in Canadian history. Named after Dr. Charles Best, the co-discoverer of insulin and an early medical director at Sanofi's Toronto campus, the new facility spans over 194,000 square feet on the 52-acre campus. The company said it will: provide antigen for Sanofi's Fluzone High-Dose influenza vaccine, increasing supply availability in Canada and other countries around the world; strategically grow Canada's biomanufacturing sector; and install industrial scale capacity to strengthen Canada's preparedness for future pandemics. The building is the anchor facility in an end-to-end influenza vaccine production chain, which spans drug substance and also formulation, filling, inspection and packaging (FFIP), Sanofi said. It is part of a broader $2-billion capital build-out across Sanofi's Toronto real estate portfolio by 2028, which includes: \"Sanofi's continued investment in Canada's operations spans R&D, production and delivery of vaccines and medicines to protect Canadians,\" Sanofi Canada country lead James Guy said. \"Today marks a strategic...",
    "summary": "Sanofi is undertaking a $2 billion capital build-out across its Toronto real estate portfolio, to be completed by 2028.",
    "location": "Toronto, Ontario, Canada",
    "planning": true,
    "image_url": "https://squall.nyc3.digitaloceanspaces.com/media/posts/2026091632-sanofi-facility.jpg",
    "confidence": 0.9,
    "assets_tags": [
      "office"
    ],
    "published_at": "2026-09-24T15:11:17Z",
    "location_data": [
      {
        "city": "Toronto",
        "state": "Ontario",
        "region": "Northern America",
        "country": "Canada",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "It is part of a broader $2-billion capital build-out across Sanofi's Toronto real estate portfolio by 2028, which includes: \"Sanofi's continued investment in Canada's operations spans R&D, production and delivery of vaccines and medicines to protect Canadians,\" Sanofi Canada country lead James Guy said.",
    "amount_normalized": 2000000000
  }
}

curl https://signals.autobound.ai/v1/signals/824f8d2a-07ce-1df2-1b53-512a44a66459 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"sanofi.com","limit":20}'